SOPHiA GENETICS Partners with Jessa Ziekenhuis for Precision Oncology Solutions

viernes, 5 de septiembre de 2025, 4:03 am ET1 min de lectura
SOPH--

SOPHiA GENETICS has partnered with Jessa Ziekenhuis in Belgium to bring cutting-edge genomic testing and oncology research to cancer patients. The hospital will adopt SOPHiA DDM™ across its pathology operations, unifying its next-generation sequencing workflows under a single platform. This collaboration aims to enhance clinical decision-making and research capabilities, streamline operations, and improve efficiency, harmonization, and compliance with national guidelines.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios